ClearTrial CEO Mike Soenen Named to Prestigious PharmaVOICE 100

Company co-founder recognized as one of the most inspiring and motivating people in the life-sciences industry by PharmaVOICE magazine

Chicago, IL – August 10, 2010

ClearTrial, the leading provider of Clinical Trial Operations (CTO) software, announced today that ClearTrial CEO Mike Soenen has been named to the exclusive PharmaVOICE 100 for 2010.  In its special July/August issue, PharmaVOICE revealed its annual list of the 100 most inspiring and motivating people in the life-sciences industry as identified by the publication’s readers. Soenen was recognized for his singular achievement in leading ClearTrial's rapid growth and the widespread adoption of its software by the life sciences industry.

“Mike has taken ClearTrial from a few employees and a product idea to a company whose software today is relied on by seven of the top 10 biotech companies and many of the largest companies in the industry to plan, source, and track their clinical trials faster and more accurately,” said Taren Grom, Editor-in-Chief and Co-Founder, PharmaVOICE.  “It’s this type of drive and innovative thinking that embodies the type of leader we look to honor with the PharmaVOICE 100.”

Soenen co-founded ClearTrial in 2004, foreseeing the timeline, cost, and resource pressures now roiling the industry, along with the need for innovative software solutions to help biopharmaceutical and medical device companies gain greater efficiency in clinical development.  He led the charge to create the guiding principles for a new type of clinical software:

  • Fast, accurate, and easy to use
  • Incorporates comprehensive global clinical knowledge
  • Supports unique business processes of each sponsor company

To develop the software, Soenen assembled a team of life sciences experts with extensive experience in clinical operations, finance, outsourcing, and project management, and paired them with top-notch software architects. Just as importantly, he led his team to incorporate best practices from industries that had successfully answered the challenges now faced by the life sciences industry.

The result?  Today, trial sponsors worldwide rely on ClearTrial software to:

  • Compress clinical study timelines and  reduce study costs, while maintaining study achievability
  • Accelerate delivery of accurate, defensible, and achievable study budgets
  • Reduce outsourcing cycle-times from RFP to final contract while increasing negotiation leverage

"I'm honored to have been named to the PharmaVOICE 100 for 2010," Soenen said.  "To me this is really a testament to the hard work and dedication of everyone at ClearTrial.  Their knowledge, passion, and innovation are the foundation for everything we've accomplished to help the industry bring new treatments to market faster and more affordably."

Click here to read the complete PharmaVOICE 100 profile on Mike Soenen.

About ClearTrial®

ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, an integrated system for clinical operations planning, forecasting, outsourcing, and project tracking. ClearTrial’s award-winning software helps life sciences companies streamline their clinical operations from Plan to Payment™ without sacrificing quality of results, providing executives and functional leaders in clinical operations, resource planning, finance, outsourcing, and project management with a common platform that promotes speed, accuracy, and consistency throughout the organization. For more information please visit http://www.cleartrial.com.

ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.


About PharmaVOICE and the PharmaVOICE 100

PharmaVOICE is expressly written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic life-sciences industry. PharmaVOICE reaches more than 17,500 readers every month in print and 70,000 with its digital edition. Established six years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry.

For more information contact:

Mike Lange
ClearTrial
+1 630.986.9800 x112
mlange@cleartrial.com